Insight Molecular Diagnostics Inc. (IMDX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $103k
- Jun 24 · Plan not stated
- Form 4 sales
- 7
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 salePlan not statedJul 5 2019
Sold 2.3M shares at $2.00 ($4.5M)
Biotime INC, 10% owner
Sold 15.3% of holdings ($29.3M position)12.4M shares leftFirst sale on recordFiling
- 2 Form 4 saleUnusualSep 11 +68 days
Sold 4M shares at $1.66 ($6.6M)
Lineage Cell Therapeutics, Inc., 10% owner
Sold 32.2% of holdings ($20.6M position)8.4M shares leftFiling
- 3 Form 4 saleUnusualJan 2 +113 days
Sold 2.4M shares at $2.16 ($5.1M)
Lineage Cell Therapeutics, Inc., Other
Sold 28.3% of holdings ($18.2M position)6M shares leftFiling
- 4 Form 4 salePlan not statedDec 22 +355 days
Sold 42,800 shares at $0.31 ($13k)
Kingsley Alfred D, Director
Sold 11.8% of holdings ($110k position)318,503 shares leftFirst sale on recordFiling
- 5 Form 4 salePlan not statedDec 23 +1 day
Sold 900 shares at $2.55 ($2k)
Kingsley Alfred D, Director
Sold 0.3% of holdings ($815k position)318,840 shares leftFiling
- 6 Form 4 saleUnusualMay 18 +511 days
Sold 8,128 shares at $1.14 ($9k)
Yu Li, VP Cntrllr/Prncpl Acctng Offcr
Sold 32.5% of holdings ($28k position)16,872 shares leftFirst sale on recordFiling
- 7 Form 4 salePlan not statedJun 24 +37 days
Sold 99,386 shares at $1.03 ($103k)
Pura Vida Investments, LLC, 10% owner
Sold 1.2% of holdings ($8.9M position)8.5M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (7)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2022 | Pura Vida Investments, LLC | 10% owner | Form 4 sale | 99,386 | $103k | 1.2% | Plan not stated | SEC |
| May 18, 2022 | Yu Li | VP Cntrllr/Prncpl Acctng Offcr | Form 4 sale | 8,128 | $9k | 32.5% | Unusual | SEC |
| Dec 23, 2020 | Kingsley Alfred D | Director | Form 4 sale | 900 | $2k | 0.3% | Plan not stated | SEC |
| Dec 22, 2020 | Kingsley Alfred D | Director | Form 4 sale | 42,800 | $13k | 11.8% | Plan not stated | SEC |
| Jan 2, 2020 | Lineage Cell Therapeutics, Inc. | Other | Form 4 sale | 2.4M | $5.1M | 28.3% | Unusual | SEC |
| Sep 11, 2019 | Lineage Cell Therapeutics, Inc. | 10% owner | Form 4 sale | 4M | $6.6M | 32.2% | Unusual | SEC |
| Jul 5, 2019 | Biotime INC | 10% owner | Form 4 sale | 2.3M | $4.5M | 15.3% | Plan not stated | SEC |